Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cypress Bioscience, Inc.

http://www.cypressbio.com

Latest From Cypress Bioscience, Inc.

MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other

The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.

Commercial Sales & Earnings

Medtronic Partners With Rune Labs To Explore New Frontiers In Deep Brain Stimulation

Rune Labs will collect data from 1,000 patients fitted with Medtronic’s Percept DBS device and search for previously unknown patterns in Parkinson’s disease patients.

Deals Neurology

The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics

How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? At a recent roundtable event, the CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.

Market Access In Vitro Diagnostics

Finance Watch: 2021 Biopharma VC Funding Tops Full-Year 2020 Total

Private Company Edition: The industry raised $28bn in venture capital through the third quarter, breaking the record $27.4bn raised last year. Also, big pharmas backed a start-up lab in Israel, plus mega-rounds for CinCor Pharma ($143m) and Rectify Pharmaceuticals ($100m), while Cerecin raises $40m.

Financing Innovation
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Services
  • In Vitro Diagnostics
    • Therapeutic Drug Monitoring
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Other Names / Subsidiaries
    • Cellatope Corporation
    • Proprius Pharmaceuticals, Inc., Ramius LLC
    • Royalty Pharma
UsernamePublicRestriction

Register